Search Results for: Mucilages not modified
drug platforms more diverse, expanding beyond the traditional small molecules, monoclonal antibodies and peptides. advancements in biotechnology have expanded our toolkit of drug modalities. this provides an opportunity to design therapeutics for disease mechanisms previously considered difficult, if not
can act within the body, and how it can be administered. for example, small molecules, which are less than kda, are able to pass across cell membranes to reach targets in the cell, and most are delivered orally. conversely, large molecules such as mabs which can be as large as - kda, are generally not...
https://www.astrazeneca.com/what-science-can-do/drug-modalities.html